Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact
Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Lanton Law Interviewed by Pharmacy Times Over Prescription Drug Price Executive Order

Lanton Law was quoted in Pharmacy Times’ article titled “President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%.” The article can be accessed here.

healthcare, pharmaceuticals, pharmacy benefit manager, prescription drug costs, PhRMARon LantonMay 14, 2025prescription drug prices, Executive Order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, Most-Favored-Nation (MFN) Pricing, MFN, healthcare, prescription, pharmaceutical, drug manufacturer
0 Likes
Previous

Bipartisan Bill Aimed At Expanding CMS Coverage Of Rx Digital Therapeutics Re-Introduced

digital health, Digital Therapeutics, healthcare, technology, telecommunications, telehealthRon LantonMay 14, 2025The Access to Prescription Digital Therapeutics Act of 2025, digital therapeutics
Next

Understanding the 2025 Executive Order on Most-Favored-Nation Drug Pricing: Implications for Healthcare Stakeholders

Ron LantonMay 13, 2025Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, Most-Favored-Nation (MFN) Pricing, Secretary of Commerce, U.S. Trade Representative, pharmaceuticals, tariffs, pharmaceutical tariffs